Efficacy and safety of the siRNA JNJ-73763989 and the capsid assembly modulator JNJ-56136379 (bersacapavir) with nucleos(t)ide analogues for the treatment of chronic hepatitis B virus infection (REEF-1): a multicentre, double-blind, active-controlled, randomised, phase 2b trial
- Resource Type
- Article
- Source
- The Lancet Gastroenterology & Hepatology; September 2023, Vol. 8 Issue: 9 p790-802, 13p
- Subject
- Language
- ISSN
- 24681253